Triptolide derivatives and preparation method and use thereof

US9809822B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9809822-B2
Application numberUS-201315100092-A
CountryUS
Kind codeB2
Filing dateDec 11, 2013
Priority dateDec 11, 2013
Publication dateNov 7, 2017
Grant dateNov 7, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Tripyolide-nucleic acid aptamer derivatives, a preparation method and use thereof are shown. The structure of the triptolide-nucleic acid aptamer derivatives is as shown by formula I, wherein the definitions of R 1 -R 7 , G, A, B, M, Z and X are described. The present invention uses a nucleic acid aptamer and triptolide or modified compounds thereof as the starting materials, and introduces a linking group A at the C-14 hydroxyl group, epoxy groups and five-membered ring lactones in triptolide, then connects it to a nucleic acid aptamer B, and obtains the triptolide-nucleic acid aptamer derivatives. The triptolide-nucleic acid aptamer derivatives of the present invention have the characteristics of good targeting, a high anti-cancer activity, low toxicity and side effects, good water solubility and high bioavailability, and the preparation method of the present invention is scientific and reasonable and has a controllable quality and good repeatability, and is thereby suitable for production.

First claim

Opening claim text (preview).

The invention claimed is: 1. A triptolide derivative, being a compound of the Formula (I): R 1 =H or OH; R 2 =H or OH; R 3 =H or OH; R 4 =H or OH; R 5 =H or OH; R 6 =H or OH; R 7 =H or OH; G is O or NH; A is —CO—, —CO—(CH 2 ) n— CO—, —CH═CH—CO—, —CH═CH—(CH 2 ) n —CO—, —CH(OH)-Ph-CO—, CH(OH)-Ph-(CH 2 ) n —CO—, —CH 2 -Ph-(CH 2 ) n— CO—, —CO—NH—CO—, —CO—NH—(CH 2 ) n —CO—, —CH 2 —CH═CH—CO—, —CH 2 —CH═CH—(CH 2 ) n— CO—, —CO—CH 2 —, —CO—O—(CH 2 ) n —CO—, —SO 2 -Ph-CO—, or —SO 2 -Ph-(CH 2 ) n —CO—; wherein 1≦n≦14; (CH 2 ) n further comprises a substituent selected from straight or branched alkyl, alkenyl, aralkyl, or alkyl aryalkyl, aryl, halogen, group with a heteroatom, heterocycle substituting one or more H in the (CH 2 ) n , the alkyl is selected from methyl, ethyl, propyl, butyl, pentyl, hexyl or heptyl; the alkenyl is selected from vinyl, 1-propenyl, allyl, isopropenyl, 1-butenyl, 2-butenyl, 3-butenyl, 1,3-butadienyl, or the E, Z isomers thereof; the aralkyl and the alkyl aralkyl is selected from benzyl, diphenylmethyl, tolyl methyl, triphenylmethyl, cinnamyl, phenethyl, styryl, phenylbutyl and neophenyl; the aryl is selected from phenyl, diphenyl, tolyl, methylbenzyl, 4,2,6-trimethylphenyl, cumenyl, di(tert-butyl) phenyl, anthryl, indenyl, naphthyl, haloaryl, haloaryl alkylphenoxy, tolyloxy, xylyl alkoxy, 2,4,6-tris tolyloxy and cumene oxy, diphenyl, anilino, toluidino, tosyl, allyl benzyl or phenyl, furanyl, pyridyl, 2-pyridyl (pyridin-2-yl), indol-1-yl, chloromethylbenzyl or phenyl, trifluoromethylbenzyl or phenyl, hydroxybenzyl or phenyl, methoxybenzyl or phenyl, ethoxybenzyl or phenyl, ethoxymethoxybenzyl or phenyl, allyloxybenzyl or phenyl, phenoxybenzyl or phenyl, acetoxybenzyl or phenyl, benzoyloxy benzyl or phenyl, methylthiobenzyl or phenyl, phenylthio benzyl or phenyl, tolylthio benzyl or phenyl, methylaminobenzyl or phenyl, dimethylaminobenzyl or phenyl, ethylaminobenzyl or phenyl, diethylaminobenzyl or phenyl, acetamidobenzyl or phenyl, carboxybenzyl or phenyl, methoxycarbonyl benzyl or phenyl, ethoxycarbonyl benzyl or phenyl, phenoxycarbonyl benzyl or phenyl, chlorophenoxycarbonyl benzyl or phenyl, N-cyclohexylcarbamoyloxy benzyl or phenyl, allyloxycarbonyl benzyl or phenyl, carbamoyl benzyl or phenyl, N-methylcarbamoyl benzyl or phenyl, N,N-dipropyl carbamoyl benzyl or phenyl, N-phenyl-carbamoyl-benzyl or phenyl, nitrobenzyl or phenyl, cyanobenzyl or phenyl, S-benzyl or phenyl, sulfate benzyl or phenyl, phosphonyl benzyl or phenyl, phosphate benzyl or phenyl and morpholino benzyl or phenyl; the halogen comprises fluorine, chlorine, bromine or iodine; the group with the heteroatom is selected from methoxy, ethoxy, propoxy, isopropoxy, n-butoxy, isobutoxy, tert-butoxy, methylthio, ethylthio, n-propylthio, iso-propylthio, n-butylthio, isobutylthio, tert-butylthio, methylsulfinyl, ethylsulfinyl, isopropyl sulfinyl, methylsulfonyl, ethylsulfonyl, isopropyl sulfonyl; the heterocycle is selected from pyridine, quinolone, thiophene, furan, oxazole, tetrazole, thiazole, imidazole, pyrazole, or indole; B is an aptamer, and the aptamer is AS1411 or Sgc8c; M is O or OH; Z is O; X is O; wherein A is connected with M, Z or X. 2. The derivative according to claim 1 , wherein A is —CO—; —CO—CH 2 —CO—, —CO—CH 2 —CH 2 —CO—, —CO—CH 2 —CH 2 —CH 2 —CO—, —CO—CH 2 —CH 2 —CH 2 —CH 2 —CO—; —CH═CH—CO—; —CH(OH)-Ph-CO—, —CH(OH)-Ph-CH 2 —CO—, —CH(OH)-Ph-CH 2 —CH 2 —CO—, —CH(OH)-Ph-CH 2 —CH 2 —CH 2 —CO—, —CH(OH)-Ph-CH 2 —CH 2 —CH 2 —CH 2 —CO—; —CH 2 -Ph-CH 2 —CO—, —CH 2 -Ph-CH 2 —CH 2 —CO—, —CH 2 -Ph-CH 2 —CH 2 —CH 2 —CO—, —CH 2 -Ph-CH 2 —CH 2 —CH 2 —CH 2 —CO—; —CO—NH—CO—, —CO—NH—CH 2 —CO—, —CO—NH—CH 2 —CH 2 —CO—, —CO—NH—CH 2 —CH 2 —CH 2 —CO—, —CO—NH—CH 2 —CH 2 —CH 2 —CH 2 —CO—; —CH 2 —CH═CH—CO—, —CH 2 —CH═CH—CH 2 —CO—, —CH 2 —CH═CH—CH 2 —CH 2 —CO—, —CH 2 —CH═CH—CH 2 —CH 2 —CH 2 —CO—, —CH 2 —CH═CH—CH 2 —CH 2 —CH 2 —CH 2 —CO; —CO—CH 2 —; —CO—O—CO—, —CO—O—CH 2 —CO—, —CO—O—CH 2 —CH 2 —CO—, —CO—O—CH 2 —CH 2 —CH 2 —CO—, —CO—O—CH 2 —CH 2 —CH 2 —CH 2 —CO—; —SO 2 -Ph-CO—, —SO 2 -Ph-CH 2 —CO—, —SO 2 -Ph-CH 2 —CH 2 —CO—, —SO 2 -Ph-CH 2 —CH 2 —CH 2 —CO—, or —SO 2 -Ph-CH 2 —CH 2 —CH 2 —CH 2 —CO—. 3. The derivative according to claim 1 , wherein the compound has the following structure: wherein, R 1 =H or OH; R 2 =H or OH; R 3 =H or OH; R 4 =H or OH; R 5 =H or OH; R 6 =H or OH; R 7 =H or OH; G is O or NH; M is O; Z is O; X is O; A is selected from —CO—, —CO—(CH 2 ) n —CO—, —CH═CH—CO—, —CH═CH—(CH 2 ) n —CO—, —CH(OH)—Ph-CO—,CH(OH)-Ph-(CH 2 ) n —CO—, —CH 2 -Ph-(CH 2 ) n —CO—, —CO—NH—CO—, —CO—NH—(CH 2 ) n —CO—, —CH 2 —CH═CH—CO—, —CH 2 —CH═CH—(CH 2 ) n CO—, —CO—CH 2 —, —CO—O—(CH 2 ) n —CO—,—SO 2 -Ph-CO— or —SO 2 -Ph-(CH 2 ) n —CO—; wherein 1≦n≦14; (CH 2 ) n further comprises a substituent selected from straight or branched alkyl, alkenyl, aralkyl, alkyl aryalkyl, aryl, halogen, group with a heteroatom, heterocycle substituting one or more H in the (CH 2 ) n , the alkyl is selected from methyl, ethyl, propyl, butyl, pentyl, hexyl or heptyl; the alkenyl is selected from vinyl, 1-propenyl, allyl, isopropenyl, 1-butenyl, 2-butenyl, 3-butenyl, 1,3-butadienyl, or the E, Z isomers thereof; the aralkyl and the alkyl aralkyl is selected from benzyl, diphenylmethyl, tolyl methyl, triphenylmethyl, cinnamyl, phenethyl, styryl, phenylbutyl or neophenyl; the aryl is selected from phenyl, diphenyl, tolyl, methylbenzyl, 4,2,6-trimethylphenyl, cumenyl, di(tert-butyl) phenyl, anthryl, indenyl, naphthyl, haloaryl, haloaryl alkylphenoxy, tolyloxy, xylyl alkoxy, 2,4,6-tris tolyloxy and cumene oxy, diphenyl, anilino, toluidino, tosyl, allyl benzyl or phenyl, furanyl, pyridyl, 2-pyridyl (pyridin-2-yl), indol-1-yl, chloromethylbenzyl or phenyl, trifluoromethylbenzyl or phenyl, hydroxybenzyl or phenyl, methoxybenzyl or phenyl, ethoxybenzyl or phenyl, ethoxymethoxybenzyl or phenyl, allyloxybenzyl or phenyl, phenoxybenzyl or phenyl, acetoxybenzyl or phenyl, benzoyloxy benzyl or phenyl, methylthiobenzyl or phenyl, phenylthio benzyl or phenyl, tolylthio benzyl or phenyl, methylaminobenzyl or phenyl, dimethylaminobenzyl or phenyl, ethylaminobenzyl or phenyl, diethylaminobenzyl or phenyl, acetamidobenzyl or phenyl, carboxybenzyl or phenyl, methoxycarbonyl benzyl or phenyl, ethoxycarbonyl benzyl or phenyl, phenoxycarbonyl benzyl or phenyl, chlorophenoxycarbonyl benzyl or phenyl, N-cyclohexylcarbamoyloxy benzyl or phenyl, allyloxycarbonyl benzyl or phenyl, carbamoyl benzyl or phenyl, N-methylcarbamoyl benzyl or phenyl, N,N-dipropyl carbamoyl benzyl or phenyl, N-phenyl-carbamoyl-benzyl or phenyl, nitrobenzyl or phenyl, cyanobenzyl or phenyl, S-benzyl or phenyl, sulfate benzyl or phenyl, phosphonyl benzyl or phenyl, phosphate benzyl or phenyl and morpholino benzyl or phenyl; the halogen comprises fluorine, chlorine, bromine and iodine; the group with the heteroatom is selected from methoxy, ethoxy, propoxy, isopropoxy, n-butoxy, isobutoxy, tert-butoxy, methylthio, ethylthio, n-propylthio, iso-propylthio, n-butylthio, isobutylthio, tert-butylthio, methylsulfinyl, ethylsulfinyl, isopropyl sulfinyl, methylsulfonyl, ethylsulfonyl, isopropyl sulfonyl; the heterocycle is selected from pyridine, quinolone, thiophene, furan, oxazole, tetrazole, thiazole, imidazole, pyrazole or indole; B is an aptamer, and the aptamer is AS1411 or Sgc8c. 4. The derivative according to claim 3 , wherein A is selected from —CO—; —CO—CH 2 —CO—, —CO—CH 2 —CH 2 —

Assignees

Inventors

Classifications

  • Sugars, nucleosides, nucleotides or nucleic acids · CPC title

  • by oxygen as hetero atom · CPC title

  • Aptamers · CPC title

  • C12N15/115Primary

    Aptamers, i.e. nucleic acids binding a target molecule specifically and with high affinity without hybridising therewith {; Nucleic acids binding to non-nucleic acids, e.g. aptamers} · CPC title

  • Conjugate · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9809822B2 cover?
Tripyolide-nucleic acid aptamer derivatives, a preparation method and use thereof are shown. The structure of the triptolide-nucleic acid aptamer derivatives is as shown by formula I, wherein the definitions of R 1 -R 7 , G, A, B, M, Z and X are described. The present invention uses a nucleic acid aptamer and triptolide or modified compounds thereof as the starting materials, and introduces a l…
Who is the assignee on this patent?
Univ Hong Kong Baptist Univ
What technology area does this patent fall under?
Primary CPC classification C12N15/115. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Nov 07 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).